vs
FIRSTSUN CAPITAL BANCORP（FSUN）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
FIRSTSUN CAPITAL BANCORP的季度营收约是Vericel Corp的1.2倍（$110.0M vs $92.9M），Vericel Corp净利率更高（25.0% vs 19.6%，领先5.4%），过去两年Vericel Corp的营收复合增速更高（34.6% vs 6.9%）
FirstSun Capital Bancorp是一家总部位于美国的金融控股公司，提供商业及个人贷款、存款产品、财富管理、财资解决方案等全面的银行金融服务，主要面向美国区域市场的个人消费者、中小企业及企业客户。
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
FSUN vs VCEL — 直观对比
营收规模更大
FSUN
是对方的1.2倍
$92.9M
净利率更高
VCEL
高出5.4%
19.6%
两年增速更快
VCEL
近两年复合增速
6.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $110.0M | $92.9M |
| 净利润 | $21.6M | $23.2M |
| 毛利率 | — | 78.7% |
| 营业利润率 | — | 24.1% |
| 净利率 | 19.6% | 25.0% |
| 营收同比 | — | 23.3% |
| 净利润同比 | -8.4% | 17.3% |
| 每股收益（稀释后） | $0.76 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSUNVCEL
| Q1 26 | $110.0M | — | ||
| Q4 25 | $110.2M | $92.9M | ||
| Q3 25 | $107.3M | $67.5M | ||
| Q2 25 | $105.6M | $63.2M | ||
| Q1 25 | $96.2M | $52.6M | ||
| Q4 24 | $98.7M | $75.4M | ||
| Q3 24 | $98.2M | $57.9M | ||
| Q2 24 | $96.2M | $52.7M |
净利润FSUNVCEL
| Q1 26 | $21.6M | — | ||
| Q4 25 | $24.8M | $23.2M | ||
| Q3 25 | $23.2M | $5.1M | ||
| Q2 25 | $26.4M | $-553.0K | ||
| Q1 25 | $23.6M | $-11.2M | ||
| Q4 24 | $16.4M | $19.8M | ||
| Q3 24 | $22.4M | $-901.0K | ||
| Q2 24 | $24.6M | $-4.7M |
毛利率FSUNVCEL
| Q1 26 | — | — | ||
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% |
营业利润率FSUNVCEL
| Q1 26 | — | — | ||
| Q4 25 | 29.0% | 24.1% | ||
| Q3 25 | 26.4% | 5.1% | ||
| Q2 25 | 31.2% | -3.2% | ||
| Q1 25 | 30.9% | -24.3% | ||
| Q4 24 | 20.4% | 24.5% | ||
| Q3 24 | 29.1% | -4.3% | ||
| Q2 24 | 32.3% | -11.5% |
净利率FSUNVCEL
| Q1 26 | 19.6% | — | ||
| Q4 25 | 22.5% | 25.0% | ||
| Q3 25 | 21.6% | 7.5% | ||
| Q2 25 | 25.0% | -0.9% | ||
| Q1 25 | 24.5% | -21.4% | ||
| Q4 24 | 16.6% | 26.3% | ||
| Q3 24 | 22.8% | -1.6% | ||
| Q2 24 | 25.5% | -8.9% |
每股收益（稀释后）FSUNVCEL
| Q1 26 | $0.76 | — | ||
| Q4 25 | $0.89 | $0.46 | ||
| Q3 25 | $0.82 | $0.10 | ||
| Q2 25 | $0.93 | $-0.01 | ||
| Q1 25 | $0.83 | $-0.23 | ||
| Q4 24 | $0.57 | $0.40 | ||
| Q3 24 | $0.79 | $-0.02 | ||
| Q2 24 | $0.88 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $413.7M | $137.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $354.6M |
| 总资产 | $8.6B | $488.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FSUNVCEL
| Q1 26 | $413.7M | — | ||
| Q4 25 | $652.6M | $137.5M | ||
| Q3 25 | $659.9M | $135.4M | ||
| Q2 25 | $785.1M | $116.9M | ||
| Q1 25 | $621.4M | $112.9M | ||
| Q4 24 | $615.9M | $116.2M | ||
| Q3 24 | $573.7M | $101.7M | ||
| Q2 24 | $535.8M | $102.5M |
股东权益FSUNVCEL
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $354.6M | ||
| Q3 25 | $1.1B | $321.9M | ||
| Q2 25 | $1.1B | $306.8M | ||
| Q1 25 | $1.1B | $295.5M | ||
| Q4 24 | $1.0B | $292.0M | ||
| Q3 24 | $1.0B | $257.5M | ||
| Q2 24 | $996.6M | $243.0M |
总资产FSUNVCEL
| Q1 26 | $8.6B | — | ||
| Q4 25 | $8.5B | $488.0M | ||
| Q3 25 | $8.5B | $453.3M | ||
| Q2 25 | $8.4B | $435.6M | ||
| Q1 25 | $8.2B | $424.6M | ||
| Q4 24 | $8.1B | $432.7M | ||
| Q3 24 | $8.1B | $390.4M | ||
| Q2 24 | $8.0B | $376.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $15.0M |
| 自由现金流经营现金流 - 资本支出 | — | $12.8M |
| 自由现金流率自由现金流/营收 | — | 13.8% |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.65× |
| 过去12个月自由现金流最近4个季度 | — | $24.7M |
8季度趋势，按日历期对齐
经营现金流FSUNVCEL
| Q1 26 | — | — | ||
| Q4 25 | $111.5M | $15.0M | ||
| Q3 25 | $49.4M | $22.1M | ||
| Q2 25 | $15.0M | $8.2M | ||
| Q1 25 | $26.4M | $6.6M | ||
| Q4 24 | $101.1M | $22.2M | ||
| Q3 24 | $48.1M | $10.2M | ||
| Q2 24 | $20.9M | $18.5M |
自由现金流FSUNVCEL
| Q1 26 | — | — | ||
| Q4 25 | $104.0M | $12.8M | ||
| Q3 25 | $47.6M | $19.5M | ||
| Q2 25 | $13.0M | $81.0K | ||
| Q1 25 | $24.3M | $-7.6M | ||
| Q4 24 | $95.7M | $8.5M | ||
| Q3 24 | $47.1M | $-9.2M | ||
| Q2 24 | $19.9M | $1.8M |
自由现金流率FSUNVCEL
| Q1 26 | — | — | ||
| Q4 25 | 94.3% | 13.8% | ||
| Q3 25 | 44.4% | 28.8% | ||
| Q2 25 | 12.3% | 0.1% | ||
| Q1 25 | 25.3% | -14.5% | ||
| Q4 24 | 97.0% | 11.2% | ||
| Q3 24 | 47.9% | -15.9% | ||
| Q2 24 | 20.6% | 3.4% |
资本支出强度FSUNVCEL
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 2.4% | ||
| Q3 25 | 1.6% | 3.9% | ||
| Q2 25 | 1.9% | 12.9% | ||
| Q1 25 | 2.1% | 27.0% | ||
| Q4 24 | 5.5% | 18.3% | ||
| Q3 24 | 1.1% | 33.5% | ||
| Q2 24 | 1.1% | 31.8% |
现金转化率FSUNVCEL
| Q1 26 | — | — | ||
| Q4 25 | 4.49× | 0.65× | ||
| Q3 25 | 2.13× | 4.35× | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 1.12× | — | ||
| Q4 24 | 6.18× | 1.12× | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | 0.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
